Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Preparation method for ubenimex gamma crystal form

A technology of ubimethoxine and crystal form, which is applied in the field of gamma crystal form of ubenimex and its preparation, can solve the problems of long volatilization time, inability to meet the requirements of large-scale crystal form preparation, etc., and achieves high production cost and production conditions. Controllable, high-quality effects

Inactive Publication Date: 2018-11-27
CHENGDU EASTON BIOPHARMACEUTICALS CO LTD +1
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This method takes a long time to volatilize and is only suitable for the preparation of small doses of crystal forms, and cannot meet the requirements for the preparation of large quantities of crystal forms.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method for ubenimex gamma crystal form
  • Preparation method for ubenimex gamma crystal form
  • Preparation method for ubenimex gamma crystal form

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] Example 1: Preparation of Ubenimex gamma crystal form

[0044] Disperse 19.40g of Ubenimex in 195ml of purified water, stir and beat at 45°C for 3h at a stirring rate of 360r / min, cool down in an ice bath to 5°C, stir and crystallize for 1h; filter under negative pressure, and place the filter cake in a vacuum at 70°C After drying in an oven for 8 hours, 17.90 g of white solid powder was obtained, with a yield of 92.3%. The HPLC purity is 99.96%, with a maximum of 0.02%. Using Cu-ka rays for X-ray powder determination, the spectrum has diffraction angles and interplanar spacings as shown in the table below:

[0045]

[0046]

[0047] The NMR results are as follows:

[0048] 1 H NMR (600MHz, DMSO): δ8.08(d,1H, J=7.8Hz), 7.32(m,5H), 3.96(q,1H, J=7.2Hz), 3.87(d,1H, J=3.0 Hz), 3.54(m, 1H), 2.96(m, 2H), 1.61(d, 2H, J=4.2Hz), 0.86(m, 6H)

[0049] 13C NMR (600MHz, DMSO): δ175.52(s, 1C), 172.09(s, 1C), 137.91(s, 1C), 129.92(s, 2C), 128.84(s, 2C), 126.94(s, 1C ),69....

Embodiment 2

[0051] Example 2: Preparation of Ubenimex gamma crystal form

[0052] Disperse 10.0g of Ubenimex in 150ml of purified water, stir and beat at 40°C for 16h, stirring at a rate of 500r / min, cool down in an ice bath to 10°C, stir and crystallize for 1h; filter under negative pressure, and place the filter cake in a vacuum at 50°C After drying in an oven for 16 hours, 9.07 g of white solid powder was obtained, with a yield of 90.07%. The HPLC purity is 99.94%, the maximum single impurity is 0.03%, and the total impurity is 0.06%.

[0053] Its NMR data and powder diffraction data are basically consistent with the data of Example 1.

Embodiment 3

[0054] Example 3: Preparation of Ubenimex gamma crystal form

[0055] Disperse 10.0g of Ubenimex in 50ml of purified water, stir and beat at 70°C for 2h, stirring at a rate of 200r / min, cool down in an ice bath to 10°C, stir and crystallize for 0.5h; filter under negative pressure, and place the filter cake at 60°C Dry in a vacuum oven for 24 hours to obtain 9.07 g of white solid powder with a yield of 90.07%. The HPLC purity is 99.94%, the maximum single impurity is 0.03%, and the total impurity is 0.06%.

[0056] Its NMR data and powder diffraction data are basically consistent with the data of Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a preparation method for a ubenimex gamma crystal form. Through controlling key parameters in the preparation method, the preparation method provided by the invention is capable of obviously increasing the yield of the gamma crystal form and acquiring a single crystal form, has high technological repeatability, is capable of achieving controllable industrial production conditions and is beneficial to large-scale industrialization.

Description

technical field [0001] The application relates to the field of pharmaceutical crystal forms, in particular to a gamma crystal form of ubenimex and a preparation method thereof. Background technique [0002] Ubenimex, its chemical name is: N-[(2S,3R)-3-amino-2-hydroxy-4-phenylbutyryl]-L-leucine; molecular formula: C 16 h 24 N 2 o 4 ; Molecular weight: 308.37; Its structural formula is as follows: [0003] [0004] Ubenimex is a dipeptide compound isolated from the culture medium of Streptomyces olivine by Japanese scholar Umezawa Hamao in 1976, which can competitively inhibit aminopeptidase B, leucine peptidase and cysteine Aspartase, etc., induce tumor cell apoptosis and promote host immune function. It can be used in conjunction with chemotherapy, radiotherapy and combined application in patients with leukemia, multiple myeloma, myelodysplastic syndrome and hematopoietic stem cell transplantation, as well as other solid tumors. [0005] U.S. Patent US4281180 provid...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C237/20C07C231/24
CPCC07B2200/13C07C231/24C07C237/20
Inventor 卢铁刚邵波李晓迅刘时奎王颖
Owner CHENGDU EASTON BIOPHARMACEUTICALS CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com